Nilotinib (Tasigna)
Also known as Tasigna
Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a tyrosine kinase inhibitor approved for the treatment of chronic myelogenous leukemia.
Source: WikipediaEstimated Total Cost: $6625.66 for an average of 28 days supply
What is it prescribed for?
Patients are most commonly prescribed nilotinib to treat leukemia, rabies, pick disease, and blastomycosis.
What drug interactions are known?
Do not take nilotinib if you are taking any of the following:
Critical Interactions
Significant Interactions
Loading...